Peter Severin
Fortuna: 203 500 $ al 31/08/2026
Fortuna: 203 500 $ al 31/08/2026
Peter Severin is the founder of Severin & Partners.
A. Current jobs include Chairman at Nordicus Partners Corp.
since 2024.
Former jobs include Head-Sales at Novartis AG, Sales Manager at GSK Plc, and Sales Manager at AstraZeneca Pharmaceuticals LP.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NORDICUS PARTNERS CORP 0,26 % | 18/06/2026 | 50.000 ( 0,26 % ) | 203 500 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NORDICUS PARTNERS CORPORATION | Presidente | 03/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Ventas & Marketing | - |
| GSK PLC | Ventas & Marketing | - |
| NOVARTIS AG | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Nordicus Partners Corp.
Nordicus Partners Corp. Chemicals: SpecialtyProcess Industries Manufactures and sells polymer materials and provides financial consulting services | Process Industries |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.